<DOC>
	<DOC>NCT01818570</DOC>
	<brief_summary>The purpose of this trial is to evaluate the effect of a single PPC‚Äê5650 dose in a human pain model including multimodal (mechanical, thermal, electrical, chemical) stimulations of the esophagus.</brief_summary>
	<brief_title>A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Signed informed consent before any study specific procedures Able to read and understand Danish. Healthy i.e. no history of chronic or recurrent pain rewarding diseases Able to cooperate and tolerate the experimental procedures (as assessed in the training visit) No over the counter medication 24h before the three visits No medications in the study period BMI 18.535.0 Caucasian No symptoms of Gastroesophageal reflux disease All men must use a safe method of contraception during the study period Any clinically relevant abnormal values from the laboratory tests on hematology, clinical chemistry, and/or urine analyses, as judged by the investigator. Participation in any other clinical trial within three months prior to the training day. Alcohol or drug abuse. Mental illnesses Allergic to the active ingredient in the investigational medicinal product</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Gastroesophageal Reflux</keyword>
</DOC>